The Delhi High Court has observed that the level of tolerance allowable for confusion among consumers is “very low” in pharmaceutical products which cannot be easily condoned.Justice Prathiba M Singh was dealing with a suit filed by Glaxo Group Limited seeking protection of the packaging and trade dress of its product name “Aufmentin” used for pharmaceutical and medicinal...